No Data
No Data
Carna Biosciences Sees FY Loss Y2.23B
Carna Biosciences: Financial results presentation materials for the 3rd quarter of the fiscal year ending 2024/12
Carna Biosciences: Summary of Financial Results for the 3rd Quarter Ending 2024/12 [Japanese GAAP] (Consolidated)
Morinaga Milk, mcdonald's, Toyo Suisan, Eisai (8th) (1429-5463)
※Please note that the above calendar is tentative and subject to change based on the company's convenience. --------------------------------------- November 8th (Fri) <1429> Japan Aqua <1435> RoboHome <143A> Ishin <1450> Tanaka Construction Industry <1451> KHC <1518> Mitsui Matsushima HD <151A> Dai <167A> Ryo
Stocks that moved the previous day part2 Money Forward, Dai Communications, Bank of Inove, etc.
Stock name <code> 22nd closing price ⇒ previous day comparison Peptide Dream <4587> 2842.5 -125.5 Stock price reaching the 3000 yen range also enhances the sense of achievement. Rakuten Bank <5838> 3110 -165 On the 22nd, bank stocks also experienced almost universal declines. Fujitsu General <6755> 1959.5 -80.5 Earnings reports approaching etc are also seen as cautionary factors. MonotaRO <3064> 2354 -103.5 Strong movements on the 21st due to movements such as raising the target stock price.
Insider decrases its stake in Carna Biosciences(4572.JP) to 3.33%
On Oct 21, モルガン・スタンレー・アンド・カンパニー・インターナショナル・ピーエルシー and related parties submitted the Change Report to Ministry of Finance. The report shows that モルガン・スタンレー・アンド・カンパニー・インターナショナル・ピーエルシー and
No Data
No Data